Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells

BMC Cancer

Tiziana Apuzzo¹  Veronica Veschi¹  Emanuela Scavo¹  Giorgio Stassi¹  Matilde Todaro²  Alice Maltese³  Antonia Moretta³  Maria Antonietta Avanzini³  Laura Catenacci³  Stefania Croce³  Melissa Mantelli³  Paolo D’Angelo⁴  Gloria Pelizzo⁵  Vincenzo Di Benedetto⁶  Valeria Calcaterra⁷ 

[1] Cellular and Molecular Pathophysiology Laboratory, Department of Surgical, Oncological and Stomatological Sciences, University of Palermo;Department of DIBIMIS, University of Palermo;Immunology and Transplantation Laboratory, Cell Factory, Pediatric Hematology Oncology Unit, Department of Maternal and Children’s Health, Fondazione IRCCS Policlinico S. Matteo;Pediatric Hematology Oncology Unit, Children’s Hospital G. Di Cristina, ARNAS Civico-Di Cristina-Benfratelli;Pediatric Surgery Department, Children’s Hospital G. Di Cristina, ARNAS Civico-Di Cristina-Benfratelli;Pediatric Surgery Unit and NICU Policlinico-Vittorio Emanuele Hospital;Pediatrics and Adolescentology Unit, Department of Internal Medicine, University of Pavia, Fondazione IRCCS Policlinico San Matteo;

关键词: Neuroblastoma;    Mesenchymal stromal cells;    Microenvironment;    Stemness;    EMT;    Children;   

DOI  :  10.1186/s12885-018-5082-2

来源: DOAJ

【 摘 要 】

Abstract Background It has been proposed that mesenchymal stromal cells (MSCs) promote tumor progression by interacting with tumor cells and other stroma cells in the complex network of the tumor microenvironment. We characterized MSCs isolated and expanded from tumor tissues of pediatric patients diagnosed with neuroblastomas (NB-MSCs) to define interactions with the tumor microenvironment. Methods Specimens were obtained from 7 pediatric patients diagnosed with neuroblastoma (NB). Morphology, immunophenotype, differentiation capacity, proliferative growth, expression of stemness and neural differentiation markers were evaluated. Moreover, the ability of cells to modulate the immune response, i.e. inhibition of phytohemagglutinin (PHA) activated peripheral blood mononuclear cells (PBMCs) and natural killer (NK) cytotoxic function, was examined. Gene expression profiles, known to be related to tumor cell stemness, Wnt pathway activation, epithelial-mesenchymal transition (EMT) and tumor metastasis were also evaluated. Healthy donor bone marrow-derived MSCs (BM-MSC) were employed as controls. Results NB-MSCs presented the typical MSC morphology and phenotype. They showed a proliferative capacity superimposable to BM-MSCs. Stemness marker expression (Sox2, Nanog, Oct3/4) was comparable to BM-MSCs. NB-MSC in vitro osteogenic and chondrogenic differentiation was similar to BM-MSCs, but NB-MSCs lacked adipogenic differentiation capacity. NB-MSCs reached senescence phases at a median passage of P7 (range, P5-P13). NB-MSCs exhibited greater immunosuppressive capacity on activated T lymphocytes at a 1:2 (MSC: PBMC) ratio compared with BM-MSCs (p = 0.018). NK cytotoxic activity was not influenced by co-culture, either with BM-MSCs or NB-MSCs. Flow-cytometry cell cycle analysis showed that NB-MSCs had an increased number of cells in the G0-G1 phase compared to BM-MSCs. Transcriptomic profiling results indicated that NB-MSCs were enriched with EMT genes compared to BM-MSCs. Conclusions We characterized the biological features, the immunomodulatory capacity and the gene expression profile of NB-MSCs. The NB-MSC gene expression profile and their functional properties suggest a potential role in promoting tumor escape, invasiveness and metastatic traits of NB cancer cells. A better understanding of the complex mechanisms underlying the interactions between NB cells and NB-derived MSCs should shed new light on potential novel therapeutic approaches.

【 授权许可】

Unknown